Young men (≤55 years) with prostate cancer (PC) may experience treatment delays despite clinical consequences of delays beyond six months. Using the United States National Cancer Database (2004-2017), we employed multivariable logistic regression analysis to retrospectively examine racial disparities in localized PC treatment delays >6 months since diagnosis. Of the 89,196 men ≤55 years included, young Black men experienced treatment delays beyond six months more frequently than young White men (7.39% vs. 3.96%; AOR 1.95, 95% CI 1.81-2.09, p < 0.001), a disparity that was greater than that among men ages 56-64 (pinteraction < 0.001). This result persisted upon restricting the sample to men with private insurance/managed care. The finding that Black men with localized PC experienced treatment delays almost twice as frequently as White men underscores access barriers that may go beyond the direct costs of care.
Prostate cancer and prostatic diseases. 2022 Feb 21 [Epub ahead of print]
Bhav Jain, Kosj Yamoah, Christopher S Lathan, Vinayak Muralidhar, Brandon A Mahal, Paul L Nguyen, Edward Christopher Dee
Massachusetts Institute of Technology, Cambridge, MA, USA., Department of Radiation Oncology, H. Lee Moffitt Cancer Center and Research Institute, University of South Florida, Tampa, FL, USA., Department of Medical Oncology, Dana-Farber Cancer Institute/Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA., Department of Radiation Oncology, Kaiser Permanente Northwest, Portland, OR, USA., Department of Radiation Oncology, University of Miami/Sylvester Comprehensive Cancer Center, Miami, FL, USA., Department of Radiation Oncology, Dana-Farber Cancer Institute/Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA. ., Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY, USA. .